Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 03  •  04:00PM ET
1.42
Dollar change
-1.14
Percentage change
-44.53
%
Index- P/E- EPS (ttm)-0.51 Insider Own57.18% Shs Outstand3.52M Perf Week-
Market Cap5.00M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.51M Perf Month-
Enterprise Value7.46M PEG- EPS next Q- Inst Own2.13% Short Float- Perf Quarter-
Income-2.02M P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Sales0.00M P/B- EPS next Y- ROA-12.10% Short Interest- Perf YTD-44.53%
Book/sh-3.06 P/C1.91 EPS next 5Y- ROE-43.37% 52W High2.90 -51.03% Perf Year-
Cash/sh0.74 P/FCF- EPS past 3/5Y-175.18% - ROIC- 52W Low2.21 -35.75% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility- - Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-887.23% Oper. Margin- ATR (14)1.07 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.25 Sales Y/Y TTM- Profit Margin- RSI (14)- Recom-
Dividend Gr. 3/5Y- - Current Ratio0.25 EPS Q/Q-574.03% SMA20-28.64% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA50-28.64% Rel Volume9.90 Prev Close2.56
Employees2 LT Debt/Eq- Earnings- SMA200-28.64% Avg Volume589.99K Price1.42
IPO- Option/ShortNo / No EPS/Sales Surpr.- - Trades Volume5,840,720 Change-44.53%
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.